DMK Annual Operating Profit
-$25.06 M
+$7.01 M+21.86%
01 December 2022
Summary:
As of January 29, 2025, DMK annual operaing income is -$25.06 million, with the most recent change of +$7.01 million (+21.86%) on December 1, 2022. During the last 3 years, it has risen by +$3.97 million (+13.67%).DMK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Quarterly Operating Profit
-$3.27 M
+$1.50 M+31.47%
01 September 2023
Summary:
As of January 29, 2025, DMK quarterly operating income is -$3.27 million, with the most recent change of +$1.50 million (+31.47%) on September 1, 2023. Over the past year, it has increased by +$1.36 million (+29.45%).DMK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK TTM Operating Profit
-$18.80 M
+$1.36 M+6.76%
01 September 2023
Summary:
As of January 29, 2025, DMK TTM operating income is -$18.80 million, with the most recent change of +$1.36 million (+6.76%) on September 1, 2023. Over the past year, it has increased by +$9.83 million (+34.35%).DMK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.9% | +29.4% | +34.4% |
| 3 y3 years | +13.7% | +40.7% | +32.3% |
| 5 y5 years | -1.5% | +63.4% | +35.2% |
DMK Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1795.4% | -166.5% | -3233.2% |
DMK Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.27 M(-31.5%) | -$18.80 M(-6.8%) |
| June 2023 | - | -$4.76 M(-25.9%) | -$20.16 M(-14.5%) |
| Mar 2023 | - | -$6.43 M(+48.0%) | -$23.57 M(-5.9%) |
| Dec 2022 | -$25.06 M(-21.9%) | -$4.34 M(-6.2%) | -$25.06 M(-12.5%) |
| Sept 2022 | - | -$4.63 M(-43.4%) | -$28.63 M(-16.3%) |
| June 2022 | - | -$8.18 M(+3.3%) | -$34.23 M(+1.6%) |
| Mar 2022 | - | -$7.91 M(-0.0%) | -$33.70 M(+5.3%) |
| Dec 2021 | -$32.07 M(+1.2%) | -$7.92 M(-22.5%) | -$32.01 M(-12.7%) |
| Sept 2021 | - | -$10.22 M(+33.6%) | -$36.65 M(+14.8%) |
| June 2021 | - | -$7.65 M(+23.0%) | -$31.93 M(-5.5%) |
| Mar 2021 | - | -$6.22 M(-50.5%) | -$33.78 M(-2.6%) |
| Dec 2020 | -$31.68 M(+9.1%) | -$12.56 M(+128.2%) | -$34.67 M(+24.9%) |
| Sept 2020 | - | -$5.50 M(-42.1%) | -$27.75 M(-4.2%) |
| June 2020 | - | -$9.50 M(+33.5%) | -$28.96 M(+6.4%) |
| Mar 2020 | - | -$7.11 M(+26.2%) | -$27.21 M(-6.3%) |
| Dec 2019 | -$29.03 M(-26.4%) | -$5.64 M(-15.9%) | -$29.03 M(-20.8%) |
| Sept 2019 | - | -$6.70 M(-13.4%) | -$36.65 M(-5.7%) |
| June 2019 | - | -$7.75 M(-13.3%) | -$38.86 M(-4.7%) |
| Mar 2019 | - | -$8.94 M(-32.6%) | -$40.78 M(+3.4%) |
| Dec 2018 | -$39.45 M(+59.8%) | -$13.26 M(+48.8%) | -$39.45 M(+14.2%) |
| Sept 2018 | - | -$8.91 M(-7.9%) | -$34.56 M(+10.2%) |
| June 2018 | - | -$9.67 M(+27.2%) | -$31.35 M(+17.9%) |
| Mar 2018 | - | -$7.61 M(-9.1%) | -$26.59 M(+7.7%) |
| Dec 2017 | -$24.69 M(-2.0%) | -$8.37 M(+46.8%) | -$24.69 M(+14.8%) |
| Sept 2017 | - | -$5.70 M(+15.9%) | -$21.51 M(-3.9%) |
| June 2017 | - | -$4.92 M(-13.9%) | -$22.38 M(-10.1%) |
| Mar 2017 | - | -$5.71 M(+10.2%) | -$24.90 M(-1.2%) |
| Dec 2016 | -$25.20 M(+82.0%) | -$5.18 M(-21.2%) | -$25.20 M(+10.1%) |
| Sept 2016 | - | -$6.58 M(-11.5%) | -$22.89 M(+16.7%) |
| June 2016 | - | -$7.43 M(+23.5%) | -$19.62 M(+24.8%) |
| Mar 2016 | - | -$6.02 M(+110.2%) | -$15.72 M(+13.5%) |
| Dec 2015 | -$13.85 M(+71.0%) | -$2.86 M(-13.5%) | -$13.85 M(+26.1%) |
| Sept 2015 | - | -$3.31 M(-6.3%) | -$10.99 M(+14.2%) |
| June 2015 | - | -$3.53 M(-14.9%) | -$9.62 M(+8.8%) |
| Mar 2015 | - | -$4.15 M(+113.7%) | -$8.84 M(+19.6%) |
| Dec 2014 | -$8.10 M(+84.3%) | - | - |
| Sept 2014 | - | -$1.94 M(-29.4%) | -$7.39 M(+15.4%) |
| June 2014 | - | -$2.75 M(+60.5%) | -$6.41 M(+45.7%) |
| Mar 2014 | -$4.40 M(+36.6%) | -$1.71 M(+74.1%) | -$4.40 M(+22.9%) |
| Dec 2013 | - | -$984.40 K(+2.9%) | -$3.58 M(+7.1%) |
| Sept 2013 | - | -$957.00 K(+29.4%) | -$3.34 M(+3.3%) |
| June 2013 | - | -$739.80 K(-17.2%) | -$3.23 M(+0.5%) |
| Mar 2013 | -$3.22 M(-33.2%) | -$893.90 K(+19.5%) | -$3.22 M(-6.9%) |
| Dec 2012 | - | -$747.80 K(-12.1%) | -$3.46 M(-6.5%) |
| Sept 2012 | - | -$851.10 K(+17.4%) | -$3.70 M(-14.5%) |
| June 2012 | - | -$724.70 K(-36.1%) | -$4.33 M(-10.1%) |
| Mar 2012 | -$4.82 M(-22.8%) | -$1.13 M(+14.6%) | -$4.82 M(+0.3%) |
| Dec 2011 | - | -$988.70 K(-33.2%) | -$4.80 M(-29.7%) |
| Sept 2011 | - | -$1.48 M(+22.1%) | -$6.83 M(+5.7%) |
| June 2011 | - | -$1.21 M(+8.5%) | -$6.46 M(+3.6%) |
| Mar 2011 | -$6.24 M(+56.8%) | -$1.12 M(-63.0%) | -$6.24 M(-13.3%) |
| Dec 2010 | - | -$3.02 M(+171.6%) | -$7.20 M(+47.9%) |
| Sept 2010 | - | -$1.11 M(+12.5%) | -$4.87 M(+13.5%) |
| June 2010 | - | -$989.10 K(-52.3%) | -$4.29 M(+7.7%) |
| Mar 2010 | -$3.98 M | -$2.07 M(+199.4%) | -$3.98 M(+78.7%) |
| Dec 2009 | - | -$692.30 K(+30.2%) | -$2.23 M(+24.1%) |
| Sept 2009 | - | -$531.80 K(-22.3%) | -$1.79 M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | -$684.30 K(+114.5%) | -$1.52 M(+29.7%) |
| Mar 2009 | - | -$319.00 K(+23.1%) | -$1.18 M(-11.1%) |
| Dec 2008 | -$1.32 M(-27.4%) | -$259.10 K(-1.1%) | -$1.32 M(-12.8%) |
| Sept 2008 | - | -$262.00 K(-21.8%) | -$1.52 M(-8.7%) |
| June 2008 | - | -$335.00 K(-28.0%) | -$1.66 M(-6.0%) |
| Mar 2008 | - | -$465.00 K(+2.5%) | -$1.77 M(-3.1%) |
| Dec 2007 | -$1.82 M(-61.1%) | -$453.60 K(+11.7%) | -$1.82 M(+31.5%) |
| Sept 2007 | - | -$406.00 K(-7.9%) | -$1.39 M(-41.7%) |
| June 2007 | - | -$441.00 K(-15.4%) | -$2.38 M(-20.3%) |
| Mar 2007 | - | -$521.00 K(+2843.5%) | -$2.98 M(-34.5%) |
| Dec 2006 | -$4.69 M(-12.5%) | -$17.70 K(-98.7%) | -$4.55 M(-33.4%) |
| Sept 2006 | - | -$1.40 M(+33.7%) | -$6.84 M(-15.8%) |
| June 2006 | - | -$1.04 M(-50.0%) | -$8.12 M(+275.8%) |
| Mar 2006 | - | -$2.09 M(-9.2%) | -$2.16 M(-59.1%) |
| Dec 2005 | -$5.36 M(-61.7%) | -$2.30 M(-13.9%) | -$5.28 M(-31.5%) |
| Sept 2005 | - | -$2.68 M(-154.5%) | -$7.70 M(-6.3%) |
| June 2005 | - | $4.91 M(-194.3%) | -$8.22 M(-48.5%) |
| Mar 2005 | - | -$5.21 M(+10.3%) | -$15.97 M(+14.0%) |
| Dec 2004 | -$14.00 M(+0.8%) | -$4.72 M(+47.9%) | -$14.00 M(+8.9%) |
| Sept 2004 | - | -$3.19 M(+12.6%) | -$12.86 M(+3.2%) |
| June 2004 | - | -$2.84 M(-12.6%) | -$12.46 M(-13.4%) |
| Mar 2004 | - | -$3.25 M(-9.3%) | -$14.39 M(+4.4%) |
| Dec 2003 | -$13.89 M(-15.6%) | -$3.58 M(+27.8%) | -$13.79 M(-5.0%) |
| Sept 2003 | - | -$2.80 M(-41.3%) | -$14.51 M(+7.8%) |
| June 2003 | - | -$4.77 M(+80.9%) | -$13.47 M(-6.8%) |
| Mar 2003 | - | -$2.64 M(-38.8%) | -$14.45 M(-12.2%) |
| Dec 2002 | -$16.46 M(-5.8%) | -$4.31 M(+145.2%) | -$16.46 M(-2.5%) |
| Sept 2002 | - | -$1.76 M(-69.5%) | -$16.87 M(-12.6%) |
| June 2002 | - | -$5.75 M(+23.9%) | -$19.30 M(+7.8%) |
| Mar 2002 | - | -$4.64 M(-1.7%) | -$17.90 M(+2.5%) |
| Dec 2001 | -$17.46 M(+49.4%) | -$4.72 M(+12.9%) | -$17.46 M(+5.2%) |
| Sept 2001 | - | -$4.18 M(-3.9%) | -$16.60 M(+7.8%) |
| June 2001 | - | -$4.35 M(+3.5%) | -$15.40 M(+10.7%) |
| Mar 2001 | - | -$4.21 M(+9.1%) | -$13.91 M(+19.0%) |
| Dec 2000 | -$11.69 M(+18.6%) | -$3.86 M(+29.0%) | -$11.69 M(+12.5%) |
| Sept 2000 | - | -$2.99 M(+4.3%) | -$10.39 M(+7.4%) |
| June 2000 | - | -$2.86 M(+44.6%) | -$9.67 M(+5.5%) |
| Mar 2000 | - | -$1.98 M(-22.5%) | -$9.17 M(-7.6%) |
| Dec 1999 | -$9.85 M(+16.4%) | -$2.55 M(+12.3%) | -$9.93 M(+3.0%) |
| Sept 1999 | - | -$2.27 M(-3.5%) | -$9.64 M(-0.3%) |
| June 1999 | - | -$2.36 M(-14.0%) | -$9.67 M(-1.5%) |
| Mar 1999 | - | -$2.74 M(+20.8%) | -$9.81 M(+13.2%) |
| Dec 1998 | -$8.47 M(+84.1%) | -$2.27 M(-1.4%) | -$8.67 M(+7.0%) |
| Sept 1998 | - | -$2.30 M(-8.0%) | -$8.10 M(+20.9%) |
| June 1998 | - | -$2.50 M(+56.3%) | -$6.70 M(+28.8%) |
| Mar 1998 | - | -$1.60 M(-5.9%) | -$5.20 M(+13.0%) |
| Dec 1997 | -$4.60 M(+24.3%) | -$1.70 M(+88.9%) | -$4.60 M(+24.3%) |
| Sept 1997 | - | -$900.00 K(-10.0%) | -$3.70 M(-2.6%) |
| June 1997 | - | -$1.00 M(0.0%) | -$3.80 M(+2.7%) |
| Mar 1997 | - | -$1.00 M(+25.0%) | -$3.70 M(+5.7%) |
| Dec 1996 | -$3.70 M(+146.7%) | -$800.00 K(-20.0%) | -$3.50 M(-5.4%) |
| Sept 1996 | - | -$1.00 M(+11.1%) | -$3.70 M(+19.4%) |
| June 1996 | - | -$900.00 K(+12.5%) | -$3.10 M(+82.4%) |
| Mar 1996 | - | -$800.00 K(-20.0%) | -$1.70 M(+112.5%) |
| Dec 1995 | -$1.50 M | -$1.00 M(+150.0%) | -$800.00 K(-500.0%) |
| Sept 1995 | - | -$400.00 K(-180.0%) | $200.00 K(-66.7%) |
| June 1995 | - | $500.00 K(+400.0%) | $600.00 K(+500.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is DMK Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual operating profit year-on-year change?
- What is DMK Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly operating profit year-on-year change?
- What is DMK Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals TTM operating profit year-on-year change?
What is DMK Pharmaceuticals annual operaing income?
The current annual operating profit of DMK is -$25.06 M
What is the all time high annual operating profit for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual operaing income is -$1.32 M
What is DMK Pharmaceuticals annual operating profit year-on-year change?
Over the past year, DMK annual operaing income has changed by +$7.01 M (+21.86%)
What is DMK Pharmaceuticals quarterly operating income?
The current quarterly operating profit of DMK is -$3.27 M
What is the all time high quarterly operating profit for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly operating income is $4.91 M
What is DMK Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, DMK quarterly operating income has changed by +$1.36 M (+29.45%)
What is DMK Pharmaceuticals TTM operating income?
The current TTM operating profit of DMK is -$18.80 M
What is the all time high TTM operating profit for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high TTM operating income is $600.00 K
What is DMK Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, DMK TTM operating income has changed by +$9.83 M (+34.35%)